New insights into cirrhotic cardiomyopathy

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1101-1108

  Møller, Søren ^a   Hove, Jens D ^b   Dixen, Ulrik ^b   Bendtsen, Flemming ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cirrhosis; Diastolic dysfunction; Hyperdynamic circulation; Portal hypertension; Prolonged QT interval; Systolic dysfunction

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARDIAC GLYCOSIDE; DIURETIC AGENT; PROPRANOLOL;

CARDIOMYOPATHY; CARDIORENAL SYNDROME; CARDIOVASCULAR MAGNETIC RESONANCE; CIRRHOTIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DRUG CONTRAINDICATION; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HEART RATE VARIABILITY; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG CONGESTION; PATHOPHYSIOLOGY; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QT PROLONGATION; REVIEW; SIGNAL TRANSDUCTION; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

CIRRHOSIS; DIASTOLIC DYSFUNCTION; HYPERDYNAMIC CIRCULATION; PORTAL HYPERTENSION; PROLONGED QT INTERVAL; SYSTOLIC DYSFUNCTION;

ANIMALS; CARDIOMYOPATHIES; HUMANS; LIVER CIRRHOSIS;

EID: 84881474050     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.089     Document Type: Review

References (89)

1. H.J. Kowalski, and W.H. Abelmann The cardiac output at rest in Laennecs cirrhosis J Clin Invest 32 1953 1025 1033
2. S. Møller, and J.H. Henriksen Cardiovascular complications of cirrhosis Gut 57 2 Feb 2008 268 278
3. Y. Iwakiri The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension J Clin Gastroenterol 41 10 Suppl. 3 Nov 2007 S288 S294
4. R.W. Schrier Water and sodium retention in edematous disorders: role of vasopressin and aldosterone Am J Med 119 7 Suppl. 1 Jul 2006 S47 S53
5. S. Møller, and J.H. Henriksen Cirrhotic cardiomyopathy J Hepatol 53 1 Jul 2010 179 190
6. H. Liu, and S.S. Lee Acute-on-chronic liver failure: the heart and systemic hemodynamics Curr Opin Crit Care 14 Feb 2011 190 194
7. T. Timoh, M.A. Protano, G. Wagman, M. Bloom, and T.J. Vittorio A perspective on cirrhotic cardiomyopathy Transplant Proc 43 5 Jun 2011 1649 1653
8. A. Zambruni, A. Di Micoli, and A. Lubisco QT interval correction in patients with cirrhosis J Cardiovasc Electrophysiol 18 1 Jan 2007 77 82
9. F. Wong, A. Villamil, and M. Merli Prevalence of diastolic dysfunction in cirrhosis and its clinical significance Hepatology 54 2011 475A
10. D. Karagiannakis, J. Vlachogiannakos, and G. Anastasiadis Cirrhotic cardiomyopathy: frequency, characteristics and relationship with bacterial translocation Hepatology 54 2011 1248A
11. M.S. Desai, S. Zainuer, and C. Kennedy Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation Gastroenterology 141 Jul 12 2011 1264 1272
12. K. Kazankov, P. Holland-Fischer, and N.H. Andersen Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging Liver Int 31 4 2011 Apr 534 540
13. A.J. Heuer, A. Gehl, and K. Püschel High rate of cardiac abnormalities in a post-mortem analysis of patients suffering from liver cirrhosis J Hepatol 54 Suppl.1 2011 S68
14. R.W. Schrier, and T. Ecder Unifying hypothesis of body fluid volume regulation: implications for cardiac failure and cirrhosis Mt Sinai J Med 68 6 Nov 2001 350 361
15. S. Møller, and J.H. Henriksen The systemic circulation in cirrhosis P. Gines, V. Arroyo, J. Rodes, R.W. Schrier, Ascites and renal dysfunction in liver disease 2nd ed. 2005 Blackwell Malden 139 155
16. S. Møller, J.S. Iversen, J.H. Henriksen, and F. Bendtsen Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems Am J Physiol Heart Circ Physiol 292 Feb 9 2007 H2966 H2972
17. S. Møller, J.H. Henriksen, and F. Bendtsen Central- and non-central blood volumes in cirrhosis. Relation to anthropometrics and gender Am J Physiol Gastrointest Liver Physiol 284 Feb 26 2003 G970 G979
18. R. Wiest, and R.J. Groszmann The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough Hepatology 35 2 Feb 2002 478 491
19. A. Lagi, G. Laffi, and S. Cencetti Impaired sympathetic regulation of cerebral blood flow in patients with cirrhosis of the liver Clin Sci (Lond) 103 1 Jul 2002 43 51
20. S. Møller, A. Krag, J.L. Madsen, J.H. Henriksen, and F. Bendtsen Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension Liver Int 29 10 Nov 2009 1528 1537
21. S. Møller, and A. Krag Cardiorenal syndrome - a new entity? A. Gerbes, Hyponatremia and hepatorenal syndrome: progress in treatment 2011 Karger Basel 102 111
22. S. Møller, L. Hobolth, C. Winkler, F. Bendtsen, and E. Christensen Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis Gut 60 Sept 2011 1254 1259
23. M. Rössle Hyperdynamic circulation and portal hypertension: chicken or egg? Gut 60 Sept 2011 1167 1169
24. T.K. Glenn, H. Honar, H. Liu, H. Keurs, and S.S. Lee Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats J Hepatol 55 6 2011 1249 1255
25. S.S. Lee, J. Marty, and J. Mantz Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats Hepatology 12 3 Pt 1 Sep 1990 481 485
26. + channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis J Hepatol 35 3 Sep 2001 350 357
27. Z. Ma, S.S. Lee, and J.B. Meddings Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy J Hepatol 26 4 Apr 1997 904 912
28. A.R. Mani, S. Ippolito, R. Ollosson, and K.P. Moore Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis Hepatology 43 2006 847 856
29. S.A. Gaskari, H. Honar, and S.S. Lee Therapy insight: cirrhotic cardiomyopathy Nat Clin Pract Gastroenterol Hepatol 3 6 Jun 2006 329 337
30. G. Ceolotto, I. Papparella, and A. Sticca An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats Hepatology 48 6 Jul 21 2008 1913 1923
31. A. Mallat, F. Teixeira-Clerc, V. Deveaux, S. Manin, and S. Lotersztajn The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings Br J Pharmacol 163 7 Apr 2011 1432 1440
32. S.A. Gaskari, H. Liu, and L. Moezi Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats Br J Pharmacol 146 3 Jul 11 2005 315 323
33. H. Liu, Z. Ma, and S.S. Lee Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats Gastroenterology 118 5 May 2000 937 944
34. R.W. Schrier Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 18 7 Jul 2007 2028 2031
35. F. Wong, N. Girgrah, and J. Graba The cardiac response to exercise in cirrhosis Gut 49 2 Aug 2001 268 275
36. F. Wong Cirrhotic cardiomyopathy Hep Intl 3 1 Aug 2009 294 304
37. C.J. Limas, N.H. Guiha, and O. Lekagul Impaired left ventricular function in alcoholic cirrhosis with ascites J Lab Clin Med 89 1977 1175 1187
38. T.R. Fouad, W.M. Abdel-Razek, K.W. Burak, V.G. Bain, and S.S. Lee Prediction of cardiac complications after liver transplantation Transplantation 87 5 Mar 15 2009 763 770
39. A. Krag, F. Bendtsen, C. Mortensen, J.H. Henriksen, and S. Møller Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis Eur J Gastroenterol Hepatol 22 9 Sep 2010 1085 1092
40. Rector WGJr, O. Adair, K.F. Hossack, and S. Rainquet Atrial volume in cirrhosis: relationship to blood volume and plasma concentrations of atrial natriuretic factor Gastroenterology 99 1990 766 770
41. S. Møller, L. Søndergaard, J. Møgelvang, O. Henriksen, and J.H. Henriksen Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis Hepatology 22 1995 472 478
42. S. Pouriki, A. Alexopoulou, and C. Chrysochoou Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome Liver Int 31 Jul 2011 1388 1394
43. G. Castellanos-Pallares, N.X. Ortiz-Olvera, and L.M. Gomez-Jimenez Anatomical cardiac alterations in liver cirrhosis: an autopsy study Ann Hepatol 10 3 Jun 1 2011 321 326
44. L. Ruffa, A. Calicchia, and A. Pergolini Cirrhotic cardiomyopathy evaluated with tissue Doppler imaging is not associated with the severity of liver dysfunction in liver cirrhosis Gut Suppl. 3 2011 241
45. J.H. Henriksen, J.P. Gøetze, and S. Fuglsang Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease Gut 52 10 Oct 2003 1511 1517
46. L. Ruiz-Del-Arbol, A. Monescillo, and C. Arocena Circulatory function and hepatorenal syndrome in cirrhosis Hepatology 42 Jun 23 2005 439 447
47. F. Wong, S. Siu, P. Liu, and L.M. Blendis Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci (Lond) 101 6 Dec 2001 621 628
48. E. Sola, and P. Gines Renal and circulatory dysfunction in cirrhosis: current management and future perspectives J Hepatol 53 Aug 13 2010 1135 1145
49. F.H. Saner, T. Neumann, and A. Canbay High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients Transpl Int 24 Jan 29 2011 425 432
50. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 12 Dec 2005 1440 1463
51. B.K. De, D. Majumdar, and D. Das Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis J Hepatol 39 3 Sep 2003 315 319
52. V. Raizada, B. Skipper, W. Luo, and J. Griffith Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects J Investig Med 55 7 Nov 2007 341 359
53. M. Cazzaniga, F. Salerno, and G. Pagnozzi Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt Gut 56 6 Nov 29 2007 869 875
54. R.N. Rabie, M. Cazzaniga, F. Salerno, and F. Wong The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt Am J Gastroenterol 104 Jun 16 2009 2458 2466
55. E.W. Holt, G. Woo, and M. Trilesskaya Diastolic dysfunction defined by E/A ratio < 1 on 2-D echo is an independent predictor of liver transplantation or death in patient with cirrhosis J Hepatol 54 Suppl.1 2011 S245 S246 Ref Type: Abstract.
56. G. Therapondos, A.D. Flapan, and M.M. Dollinger Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus Liver Transpl 8 8 Aug 2002 690 700
57. M. Torregrosa, S. Aguade, and L. Dos Cardiac alterations in cirrhosis: reversibility after liver transplantation J Hepatol 42 1 Jan 2005 68 74
58. J.L. Monin, M. Monchi, and V. Gest Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography J Am Coll Cardiol 37 8 Jun 15 2001 2101 2107
59. S. Hoffmann, R. Møgelvang, and N.T. Olsen Tissue Doppler echocardiography reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease Eur J Echocardiogr 11 6 Jul 2010 544 549
60. G.B. Cranney, C.S. Lotan, and L. Dean Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography Circulation 82 1 Jul 1990 154 163
61. J.S. Lawton, B.P. Cupps, and A.K. Knutsen Magnetic resonance imaging detects significant sex differences in human myocardial strain Biomed Eng Online Aug 22 2011 10:76.:76.
62. L. Iles, H. Pfluger, and A. Phrommintikul Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 19 Nov 4 2008 1574 1580
63. M. Bernardi, S. Calandra, and A. Colantoni Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors Hepatology 27 1998 28 34
64. J.S. Bal, and P.J. Thuluvath Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation Liver Int 23 4 Aug 2003 243 248
65. W.J. Shin, Y.K. Kim, and J.G. Song Alterations in QT interval in patients undergoing living donor liver transplantation Transplant Proc 43 1 Jan 2011 170 173
66. S. Genovesi, D.M. Prata Pizzala, and M. Pozzi QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium Clin Sci (Lond) 116 12 May 14 2009 851 859
67. S. Hansen, S. Møller, F. Bendtsen, G. Jensen, and J.H. Henriksen Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes J Hepatol 47 3 Sep 2007 373 380
68. J.H. Henriksen, S. Fuglsang, F. Bendtsen, E. Christensen, and S. Møller Dyssynchronous electrical and mechanical systole in patients with cirrhosis J Hepatol 36 4 Apr 2002 513 520
69. W. Aljaroudi, H. Aggarwal, F. Iqbal, J. Heo, and A.E. Iskandrian Left ventricular dyssynchrony in patients with end-stage liver disease J Nucl Cardiol 18 Apr 9 2011 451 455
70. M. Bernardi, C. Maggioli, V. Dibra, and G. Zaccherini QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol 6 1 Feb 2012 57 66
71. A. Zambruni, F. Trevisani, P. Caraceni, and M. Bernardi Cardiac electrophysiological abnormalities in patients with cirrhosis J Hepatol 44 2006 994 1002
72. F. Trevisani, M. Merli, and F. Savelli QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt J Hepatol 38 4 Apr 2003 461 467
73. A.R. Mani, S. Montagnese, and C.D. Jackson Decreased heart rate variability in patients with cirrhosis relates to the presence and severity of hepatic encephalopathy Am J Physiol Gastrointest Liver Physiol 296 Nov 2008 G330 G338
74. D. Pateron, P. Beyne, and T. Laperche Elevated circulating cardiac troponin I in patients with cirrhosis Hepatology 29 3 1999 640 643
75. J.P. Gøtze, G. Jensen, and S. Møller BNP and N-terminal proBNP are both extracted in the normal kidney Eur J Clin Invest 36 1 Jan 2006 8 15
76. A. Krag, F. Bendtsen, J.H. Henriksen, and S. Møller Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites Gut 59 1 Jan 2010 105 110
77. T. Gustot, F. Durand, D. Lebrec, J.L. Vincent, and R. Moreau Severe sepsis in cirrhosis Hepatology 50 Aug 31 2009 2022 2033
78. S.A. Alqahtani, T.R. Fouad, and S.S. Lee Cirrhotic cardiomyopathy Semin Liver Dis 28 1 Feb 2008 59 69
79. M. Rössle, and A.L. Gerbes TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update Gut 59 7 Jul 2010 988 1000
80. L. Ruiz-Del-Arbol, J. Urman, and J. Fernandez Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 38 5 Nov 2003 1210 1218
81. A. Krag, F. Bendtsen, A.K. Burroughs, and S. Møller The cardiorenal link in advanced cirrhosis Med Hypotheses 79 1 Apr 24 2012 53 55
82. A. Kovacs, M. Schepke, J. Heller, H.H. Schild, and S. Flacke Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results Cardiovasc Intervent Radiol 33 Sep 3 2009 290 296
83. P. Gines, J. Uriz, and B. Calahorra Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis Gastroenterology 123 6 Dec 2002 1839 1847
84. C. Ripoll, R. Yotti, J. Bermejo, and R. Banares The heart in liver transplantation J Hepatol 54 Nov 11 2010 810 822
85. A.Q. Adigun, A.G. Pinto, and D.A. Flockhart Effect of cirrhosis and liver transplantation on the gender difference in QT interval Am J Cardiol 95 5 Mar 1 2005 691 694
86. J.H. Henriksen, F. Bendtsen, E.F. Hansen, and S. Møller Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis J Hepatol 40 2 Feb 2004 239 246
87. A. Zambruni, F. Trevisani, and A. Di Micoli Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis J Hepatol 48 3 Mar 2008 415 421
88. Y.K. Kim, G.S. Hwang, and W.J. Shin Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation Transplant Proc 43 5 Jun 2011 1654 1659
89. T. Serste, C. Melot, and C. Francoz Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites Hepatology 52 May 25 2010 1017 1022